Zobrazeno 1 - 10
of 64
pro vyhledávání: '"A. M. Kappelgaard"'
Autor:
A. McNair, A. M. Kappelgaard, Lund Jo, M. Damkjaer Nielsen, K. H. Tønnesen, Hans Ibsen, F. Mathiesen, P. Fårup, P.A. Gammel‐gaard, Jørn Giese, O. Munck
Publikováno v:
Acta Medica Scandinavica. 201:33-36
Autor:
A. Leth, Jørn Giese, Hans Ibsen, A. M. Kappelgaard, Hanne Hollnagel, N. J. Christensen, M. Damkjaer Nielsen
Publikováno v:
Acta Medica Scandinavica. 205:547-555
Twenty-five 40-year-old patients with mild essential hypertension, identified during a survey of a population born in 1936, were investigated. Basal and postfurosemide values for plasma renin concentration (PRC) and plasma angiotensin II concentratio
Autor:
G. S. Conway, A.-M. Kappelgaard, A. H. Andreasen, A. Keller, L. Hyldstrup, A. L. Lysgaard, Károly Rácz, Margaret Zacharin, Philippe Chanson
Publikováno v:
Osteoporosis International
Summary Growth hormone (GH) treatment in young adults with childhood-onset GH deficiency has beneficial effects on bone mass. The present study shows that cortical bone dimensions also benefit from GH treatment, with endosteal expansion and increased
Autor:
D. Russel-Jones, Z. Laron, K. Takano, A. M. Kappelgaard, D. De Rijdt, S. Shalet, K. H. Garvan, E Hernberg-Ståhl, S. Blethen, J. Chipman, Jens Otto Lunde Jørgensen, F. Casaneuva, D. Hoffman, M. Thorner, Robert C. Baxter, C. Strasburger, Jens Sandahl Christiansen, A. Black, S. Malozowski, R C Cuneo, Lena M. S. Carlsson, R. Hintz, M. Hartman, A. Attanasio, B. A. Bengtsson, David R. Clemmons, K. Attie, M. Irie, P. Sizonenko, P. H. Sonksen, E. Ghigo
Publikováno v:
Journal of Clinical Endocrinology & Metabolism. 83:379-381
Publikováno v:
Growth Hormone & IGF Research. 24:S46
Introduction: FlexPro® PenMate® (PenMate®) (Novo Nordisk A/S, Denmark) aims to reduce needle anxiety caused by needle phobia by hiding the needle during subcutaneous injection . This study validated the safety and usability of PenMate® and the in
Publikováno v:
Growth Hormone & IGF Research. 18:S7-S8
Publikováno v:
Growth Hormone & IGF Research. 22:S86
Publikováno v:
Growth Hormone & IGF Research. 20:S29
restriction, maxillary hypoplasia, prominent heels and a variable incidence of skeletal abnormalities such as slender long bones and relatively tall vertebrae. Affected patients have a relatively poor growth response to growth hormone therapy. Nonsen
Autor:
H L Simpson, E. Eryl Bassett, P J Brown, B.-Å. Bengtsson, L. Sacca, Alexander De Merode, Jørgen S. Christiansen, P H S nksen, A-M Kappelgaard, J.K. Powrie, L Frykland, L River
Publikováno v:
Medicine & Science in Sports & Exercise. 34:113
Publikováno v:
European Journal of Clinical Investigation. 6:229-240
A two-step purification method is described for the preparation of renin substrate from human plasma. Pooled plasma from women on oral contraceptives is used for the purification. The overall yield of renin substrate is 57%, with a twenty-fold purifi